Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies
Titel:
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies
Auteur:
Patel, Dilan A. Wan, Fei Trinkaus, Kathryn Guy, Daniel G. Edwin, Natasha Watkins, Marcus Bartlett, Nancy L. Cashen, Amanda Fehniger, Todd A. Ghobadi, Armin Shah, Neha-Mehta Kahl, Brad S.